Crosstalk of Notch with p53 and p63 in cancer growth control

被引:157
作者
Dotto, G. Paolo [1 ,2 ]
机构
[1] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland
[2] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA
关键词
CELL-CYCLE ARREST; NF-KAPPA-B; TUMOR-SUPPRESSOR; FACTOR RECEPTOR; STEM-CELL; SIGNALING PATHWAYS; DOWN-REGULATION; TRANSCRIPTIONAL COACTIVATOR; NEGATIVE REGULATION; PRESENILIN-1; GENE;
D O I
10.1038/nrc2675
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Understanding the complexity of cancer depends on an elucidation of the underlying regulatory networks, at the cellular and intercellular levels and in their temporal dimension. This Opinion article focuses on the multilevel crosstalk between the Notch pathway and the p53 and p63 pathways. These two coordinated signalling modules are at the interface of external damaging signals and control of stem cell potential and differentiation. Positive or negative reciprocal regulation of the two pathways can vary with cell type and cancer stage. Therefore, selective or combined targeting of the two pathways could improve the efficacy and reduce the toxicity of cancer therapies.
引用
收藏
页码:587 / 595
页数:9
相关论文
共 157 条
[1]   Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: Implications for cancer cell fate determination after genotoxic stress [J].
Alimirah, Fatouma ;
Panchanathan, Ravichandran ;
Davis, Francesca J. ;
Chen, Jianming ;
Choubey, Divaker .
NEOPLASIA, 2007, 9 (05) :427-434
[2]   Network motifs: theory and experimental approaches [J].
Alon, Uri .
NATURE REVIEWS GENETICS, 2007, 8 (06) :450-461
[3]   Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice [J].
Amson, R ;
Lassalle, JM ;
Halley, H ;
Prieur, S ;
Lethrosne, F ;
Roperch, JP ;
Israeli, D ;
Gendron, MC ;
Duyckaerts, C ;
Checler, F ;
Dausset, J ;
Cohen, D ;
Oren, M ;
Telerman, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5346-5350
[4]   The epidemiology of UV induced skin cancer [J].
Armstrong, BK ;
Kricker, A .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 63 (1-3) :8-18
[5]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[6]   Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression [J].
Balint, K ;
Xiao, M ;
Pinnix, CC ;
Soma, A ;
Veres, I ;
Juhasz, I ;
Brown, EJ ;
Capobianco, AJ ;
Herlyn, M ;
Liu, ZJ .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3166-3176
[7]   EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma [J].
Ban, Jozef ;
Bennani-Baiti, Idriss M. ;
Kauer, Max ;
Schaefer, Karl-Ludwig ;
Poremba, Christopher ;
Jug, Gunhild ;
Schwentner, Raphaela ;
Smrzka, Oskar ;
Muehlbacher, Karin ;
Aryee, Dave N. T. ;
Kovar, Heinrich .
CANCER RESEARCH, 2008, 68 (17) :7100-7109
[8]   Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling [J].
Barolo, S ;
Posakony, JW .
GENES & DEVELOPMENT, 2002, 16 (10) :1167-1181
[9]   Rel/NF-κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors [J].
Bash, J ;
Zong, WX ;
Banga, S ;
Rivera, A ;
Ballard, DW ;
Ron, Y ;
Gélinas, C .
EMBO JOURNAL, 1999, 18 (10) :2803-2811
[10]   Suppression of p53 by Notch in lymphomagenesis: Implications for initiation and regression [J].
Beverly, LJ ;
Felsher, DW ;
Capobianco, AJ .
CANCER RESEARCH, 2005, 65 (16) :7159-7168